跳至主要内容
临床试验/CTRI/2024/03/063579
CTRI/2024/03/063579尚未招募2/3 期

Comparative study between intrathecal 0.5% hyperbaric levobupivacaine and 0.5% hyperbaric bupivacaine with nalbuphine as adjuvant in elective lower segment cesarean section: A randomized clinical study

Sri Guru Ram Das Institute of Medical Sciences and research1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年3月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
To evaluate the effects of bupivacaine and levobupivacaine with combination of nalbuphine in terms of onset, regression and duration of sensory and motor blockade, time to requirement of first rescue analgesia for LSCS.

研究概览

简要总结

Rationale: To compare the effectiveness of intrathecal 0.5% hyperbaric levobupivacaine and 0.5% hyperbaric bupivacaine with nalbuphine as an adjuvant in providing postoperative pain relief and patient satisfaction following elective lower segment cesarean section. The research intends to guide anesthesia choices, potentially enhancing the cesarean section recovery experience.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Patients undergoing elective LSCS.

排除标准

  • Patients with cardiovascular diseases.
  • Contraindications to regional anesthesia such as local infections/sepsis at the site of lumbar puncture, anatomical disorders of spine, shock, any bleeding disorder and patient on anticoagulants.
  • Hypersensitivity to study drugs
  • History of opioid dependence
  • Fetal distress.

结局指标

主要结局

To evaluate the effects of bupivacaine and levobupivacaine with combination of nalbuphine in terms of onset, regression and duration of sensory and motor blockade, time to requirement of first rescue analgesia for LSCS.

时间窗: till the end of surgery

次要结局

  • 1. To compare the hemodyanamic effects of bupivacaine and levobupivacaine(with nalbuphine as adjuvant in elective lower segment cesarean section.)

研究者

发起方
Sri Guru Ram Das Institute of Medical Sciences and research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Chiteshwar Walia

Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar

研究点 (1)

Loading locations...

相似试验